Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia
about
NeuroAIDS, drug abuse, and inflammation: building collaborative research activitiesRole of neuroimaging in HIV-associated neurocognitive disordersHIV and aging: effects on the central nervous systemMagnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.Magnetic resonance spectroscopy and its applications in psychiatry.Alcoholism and AIDS: magnetic resonance imaging approaches for detecting interactive neuropathology.The changing pattern of HIV neuropathology in the HAART era.Neuroimaging of HIV-associated neurocognitive disorders (HAND)Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: A coregistered (1)H MRS and SPECT study.Cerebral MR spectroscopy in neurologically asymptomatic HIV-infected patients.Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementiaMedication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disordersImpact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques.Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.Neurological manifestations of HIV-1 infection in the HAART era.Antiretroviral treatment of central nervous system HIV-1 infection: a review.HIV and the central nervous system.Brain ageing in the new millennium.The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infectionsHippocampal MR spectroscopic abnormalities in a cohort of syphilitic patients with HIV and neurosyphilis infection.Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy.A newly designed radiation therapy protocol in combination with prednisolone as treatment for meningoencephalitis of unknown origin in dogs: a prospective pilot study introducing magnetic resonance spectroscopy as monitor tool.Neurologic aspects of HIV infection in infants and children: therapeutic approaches and outcome.Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART.Imaging neuroinflammation? A perspective from MR spectroscopy.White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients2D MR Spectroscopy Combined with Prior-Knowledge Fitting Is Sensitive to HCV-Associated Cerebral Metabolic Abnormalities.Comparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral Therapy.Whole brain diffusion tensor imaging in HIV-associated cognitive impairmentMetabolic markers of neuronal injury correlate with SIV CNS disease severity and inoculum in the macaque model of neuroAIDSInteractions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-CameroonGlycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS.Compensatory activation in fronto-parietal cortices among HIV-infected persons during a monetary decision-making task.Alterations in brain metabolism during the first year of HIV infection.Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infectionGlobal gray and white matter metabolic changes after simian immunodeficiency virus infection in CD8-depleted rhesus macaques: proton MRS imaging at 3 T.
P2860
Q23915009-B998D2D6-214A-4A7E-8508-CAFFA6539AFBQ26852705-5B753342-620A-4F49-9FAC-2FD5E784D034Q27025018-D173BFC2-6DA7-4C75-BCDF-4172E1A0CA49Q30624704-36B6A092-5832-44DC-BC25-B9F4F93747D9Q30684591-AF9724E3-8B08-4576-BB6D-AF59AD6DF32BQ30712330-0401955C-C502-4E44-A6D7-1353C8BC64A8Q30797688-CFDA14DB-7345-4164-9DBC-97C443EB385DQ30854917-9B3A5893-AC19-486F-8E31-9E9BBFDF9002Q31651608-84DEABCB-EBFA-4AB1-99F3-7283DA30AC4BQ33186698-639EDE37-8F3A-4C58-A817-F11488F6C08CQ33525781-478FE6F0-A464-411A-97AA-E7CEF3A6B339Q33855976-EC3D622B-B9FC-4242-B723-1ABEDD98EA66Q33919945-4917619A-DFA9-410B-B7A4-E44AC981F890Q34016222-2923AC44-B420-4958-A3F0-2FDC1CFCBA49Q34033558-D5D9C7B6-3CE7-4F7F-B795-D31F5B29B810Q34113118-D39E2F9D-8B08-49A4-ACB5-21CAF8D62051Q34238406-101728E0-0F11-4C04-8CAA-4A6155E57AE7Q34378701-7DD93D5D-FDE3-43FF-A978-3311D223ABB1Q34459372-405135D2-7D48-4B5A-8CDD-FCF0B867A565Q34563942-F2C38741-4650-49A5-A6EE-C24527621408Q34625093-9E516313-5FC2-41A6-BA4D-913DF5CC1029Q34787585-623ED407-7D60-4974-BDAC-9C9FE21823C9Q34987714-A21DA9B6-C7B9-473C-9AA0-2393ECC24F66Q35039830-8EE15E42-6457-40A2-8D64-7D53E4D18C2AQ35047961-F274413A-6EA2-439D-8615-33CA32A382B5Q35065220-A2FC0181-D97F-4B6D-B637-0D961563B9BFQ35568896-4EFB09CA-8CB0-47BC-BC6D-0D3E1D64C3EAQ35824849-3D481F22-CD6D-45B4-8E52-BEAFE479108DQ35828301-37BD7094-0CDC-4DD3-A75D-FFD693E3E4B0Q36111496-9D0CB791-0D99-4618-BAEC-DE61BF8D90A0Q36294152-41DFE894-8E53-4835-8372-AC771FB7DCCCQ36511545-F90DCCDD-8705-4599-B091-9936314E7F61Q36920071-6B017CC2-8197-4E71-B4A2-CB4FCF90BE5DQ36984709-210B2AF0-3B47-4F86-A64E-82657FD7E902Q37001750-3C0F009B-41E3-4406-B473-F4212E3F276CQ37015510-8BECD884-7253-4BFB-9651-EB9C45FDD605Q37019338-D5DF7A69-DA71-4C36-BC1C-EFD1BD689ED4Q37122230-96B9E3C7-EF3E-4FC3-A088-2B4742FB77A4Q37180404-E7934BC5-70C4-430A-8AD6-4612692B7F37Q37201040-EB5141CD-C9C6-47BD-A118-3B59730DF420
P2860
Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Highly active antiretroviral t ...... rmalities in mild HIV dementia
@ast
Highly active antiretroviral t ...... rmalities in mild HIV dementia
@en
Highly active antiretroviral t ...... rmalities in mild HIV dementia
@nl
type
label
Highly active antiretroviral t ...... rmalities in mild HIV dementia
@ast
Highly active antiretroviral t ...... rmalities in mild HIV dementia
@en
Highly active antiretroviral t ...... rmalities in mild HIV dementia
@nl
prefLabel
Highly active antiretroviral t ...... rmalities in mild HIV dementia
@ast
Highly active antiretroviral t ...... rmalities in mild HIV dementia
@en
Highly active antiretroviral t ...... rmalities in mild HIV dementia
@nl
P2093
P921
P356
P1433
P1476
Highly active antiretroviral t ...... rmalities in mild HIV dementia
@en
P2093
P356
10.1212/WNL.53.4.782
P407
P50
P577
1999-09-11T00:00:00Z